title: An eleven year follow-up of delayed-type hypersensitivity testing for the identification of HIV-1 infected patients at increased risk of developing AIDS.
abstract: The objective of this study was to investigate whether testing of delayed-type hypersensitivity (DTH) to recall antigens could be used to identify HIV-1 infected patients at increased risk of death or developing AIDS. Eighty-five HIV-1 infected Swedish homosexual men were tested for DTH using a commercially available kit with 7 recall antigens (Multitest, Mérieux). The patients were followed prospectively for 11 years or until death. The 11-year actuarial progression rate to AIDS was 69% and to death 60%. Older age was identified as a factor predisposing to rapid progression independent of cell-mediated immunity measured by DTH. Patients with a subnormal DTH had a significantly more rapid progression to AIDS and death than did patients with normal DTH, and the time between AIDS diagnosis and death was shorter. For patients with a multiscore (MS) < 10 mm, the median time to AIDS was 59 months, the median time to death 88 months, and the median time from AIDS diagnosis to death 11 months, compared to 106, 139, and 25 months, respectively, for patients with MS > or = 10 mm. Of the individual antigens, only a negative reaction to tuberculin was independently predictive of progression to all 3 endpoints, while a negative reaction to tetanus was independently predictive of progression to death. Thus, determination of DTH improves the early recognition of patients at increased risk of progressive disease.
authors.affiliation: Department of Dermatovenereology (Venhälsan), Södersjukhuset, Stockholm, Sweden.
authors.forename: A
authors.initials: A
authors.lastname: Karlsson
authors.forename: L
authors.initials: L
authors.lastname: Moberg
authors.forename: G
authors.initials: G
authors.lastname: Bratt
authors.forename: M
authors.initials: M
authors.lastname: Halvarsson
authors.forename: G
authors.initials: G
authors.lastname: von Krogh
authors.forename: L
authors.initials: L
authors.lastname: Morfeldt
authors.forename: E
authors.initials: E
authors.lastname: Sandström
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology* / Q000276:immunology*; D000328:Adult; D005500:Follow-Up Studies; D015488:HIV Antigens / Q000032:analysis*; D015658:HIV Infections / Q000150:complications / Q000175:diagnosis / Q000276:immunology; D015497:HIV-1 / Q000276:immunology*; D018451:Homosexuality, Male; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000150:complications / Q000175:diagnosis / Q000276:immunology*; D007159:Immunologic Tests; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016016:Proportional Hazards Models; D012044:Regression Analysis; D012307:Risk Factors; D015996:Survival Rate; D013548:Sweden / Q000453:epidemiology
chemical_list: D015488:HIV Antigens